HC Wainwright Has Bullish Estimate for RIGL Q4 Earnings

1 day ago · Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) - Research analysts at HC Wainwright boosted their Q4 2024 earnings estimates for Rigel Pharmaceuticals in a note issued to investors on Tuesday, January 14th.HC Wainwright analyst J. Pantginis now forecasts that …

$15.00
OFF

Rigel Pharmaceuticals (NASDAQ:RIGL) Price Target Increased To …

1 week from now

Aug 13, 2024 · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its price target upped by HC Wainwright from $15.00 to $57.00 in a research note released on Friday, Benzinga …

americanbankingnews.com

$7
OFF

RIGL - Rigel Pharmaceuticals Stock Price And Quote - FINVIZ.com

1 week from now

Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open. RIGL Rigel Pharmaceuticals ... H.C. Wainwright: Buy: $7: Mar-09-17: …

finviz.com

$25.57
OFF

Rigel Pharmaceuticals (NASDAQ:RIGL) Stock, Analyst Ratings, Price ...

1 week from now

Rigel Pharmaceuticals Inc has a consensus price target of $25.57 based on the ratings of 7 analysts. The high is $57 issued by HC Wainwright & Co. on December 10, 2024.The low is …

benzinga.com

$57.00
OFF

Strong Commercial Performance And Promising Pipeline Drive …

1 week from now

4 days ago · Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Rigel (RIGL – Research Report). The associated price target remains the same with $57.00. …

businessinsider.com

$0.30
OFF

HC Wainwright Has Bullish Forecast For BCTX Q1 Earnings

1 week from now

Dec 6, 2024 · Read HC Wainwright Has Bullish Forecast for BCTX Q1 Earnings at ETF Daily News ... up from their previous estimate of ($0.30). HC Wainwright has a “Buy” rating and a …

etfdailynews.com

$2.73
OFF

HC Wainwright Has Bullish Estimate For RAPT FY2024 Earnings

1 week from now

Nov 28, 2024 · The consensus estimate for RAPT Therapeutics’ current full-year earnings is ($2.73) per share. HC Wainwright also issued estimates for RAPT Therapeutics’ Q4 2024 …

etfdailynews.com

$0.65
OFF

What Is HC Wainwright’s Estimate For Quantum-Si Q2 Earnings?

1 week from now

Nov 25, 2024 · The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q3 2025 earnings at ($0.19) …

defenseworld.net

$0.75
OFF

HC Wainwright Has Bullish Estimate For ACRS FY2024 Earnings

1 week from now

Dec 25, 2024 · The consensus estimate for Aclaris Therapeutics' current full-year earnings is ($0.75) per share. HC Wainwright also issued estimates for Aclaris Therapeutics' Q4 2024 …

marketbeat.com

$0.33
OFF

Research Analysts Issue Forecasts For HIVE FY2025 Earnings

1 week from now

Nov 18, 2024 · HC Wainwright analyst M. Colonnese now forecasts that the company will post earnings per share of ($0.33) for the year, up from their prior estimate of ($0.35). HC …

marketbeat.com

$0.60
OFF

Q4 Earnings Forecast For Birkenstock Issued By William Blair

1 week from now

Dec 15, 2024 · William Blair also issued estimates for Birkenstock’s Q2 2025 earnings at $0.60 EPS, Q3 2025 earnings at $0.69 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at …

etfdailynews.com